These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 8532907)

  • 1. Hyperfractionation in the reirradiation of head and neck cancers. Result of a pilot study.
    Benchalal M; Bachaud JM; François P; Alzieu C; Giraud P; David JM; Daly-Schveitzer N
    Radiother Oncol; 1995 Sep; 36(3):203-10. PubMed ID: 8532907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hyperfractionated reirradiation after salvage surgery in cervico-facial carcinoma. Result of a pilot study in 14 patients].
    Benchalal M; Bachaud JM; François P; Alzieu C; Giraud P; David JM; Daly-Schveitzer N
    Cancer Radiother; 1997; 1(1):68-73. PubMed ID: 9265536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemo-reirradiation in persistent/recurrent head and neck cancers.
    Nagar YS; Singh S; Datta NR
    Jpn J Clin Oncol; 2004 Feb; 34(2):61-8. PubMed ID: 15067097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How successful is high-dose (> or = 60 Gy) reirradiation using mainly external beams in salvaging local failures of nasopharyngeal carcinoma?
    Teo PM; Kwan WH; Chan AT; Lee WY; King WW; Mok CO
    Int J Radiat Oncol Biol Phys; 1998 Mar; 40(4):897-913. PubMed ID: 9531376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Full-dose reirradiation for unresectable head and neck carcinoma: experience at the Gustave-Roussy Institute in a series of 169 patients.
    De Crevoisier R; Bourhis J; Domenge C; Wibault P; Koscielny S; Lusinchi A; Mamelle G; Janot F; Julieron M; Leridant AM; Marandas P; Armand JP; Schwaab G; Luboinski B; Eschwege F
    J Clin Oncol; 1998 Nov; 16(11):3556-62. PubMed ID: 9817275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reirradiation for rectal cancer and surgical resection after ultra high doses.
    Mohiuddin M; Lingareddy V; Rakinic J; Marks G
    Int J Radiat Oncol Biol Phys; 1993 Dec; 27(5):1159-63. PubMed ID: 8262842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IMRT reirradiation of head and neck cancer-disease control and morbidity outcomes.
    Sulman EP; Schwartz DL; Le TT; Ang KK; Morrison WH; Rosenthal DI; Ahamad A; Kies M; Glisson B; Weber R; Garden AS
    Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):399-409. PubMed ID: 18556144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pilot study of postoperative reirradiation, chemotherapy, and amifostine after surgical salvage for recurrent head-and-neck cancer.
    Machtay M; Rosenthal DI; Chalian AA; Lustig R; Hershock D; Miller L; Weinstein GS; Weber RS
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):72-7. PubMed ID: 15093901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Full dose reirradiation combined with chemotherapy after salvage surgery in head and neck carcinoma.
    De Crevoisier R; Domenge C; Wibault P; Koscielny S; Lusinchi A; Janot F; Bobin S; Luboinski B; Eschwege F; Bourhis J
    Cancer; 2001 Jun; 91(11):2071-6. PubMed ID: 11391587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dosimetric Factors and Toxicity in Highly Conformal Thoracic Reirradiation.
    Binkley MS; Hiniker SM; Chaudhuri A; Maxim PG; Diehn M; Loo BW; Shultz DB
    Int J Radiat Oncol Biol Phys; 2016 Mar; 94(4):808-15. PubMed ID: 26831903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reirradiation of Recurrent and Second Primary Head and Neck Cancer With Proton Therapy.
    McDonald MW; Zolali-Meybodi O; Lehnert SJ; Estabrook NC; Liu Y; Cohen-Gadol AA; Moore MG
    Int J Radiat Oncol Biol Phys; 2016 Nov; 96(4):808-819. PubMed ID: 27788954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton therapy for reirradiation of progressive or recurrent chordoma.
    McDonald MW; Linton OR; Shah MV
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1107-14. PubMed ID: 24267972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reirradiation after salvage surgery and microvascular free flap reconstruction for recurrent head and neck carcinoma.
    Suh JD; Kim BP; Abemayor E; Sercarz JA; Nabili V; Liu JH; Juillard GJ; Blackwell KE
    Otolaryngol Head Neck Surg; 2008 Dec; 139(6):781-6. PubMed ID: 19041503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose reirradiation with intensity-modulated radiotherapy for recurrent head-and-neck cancer: disease control, survival and toxicity.
    Duprez F; Berwouts D; Madani I; Bonte K; Boterberg T; De Gersem W; Deron P; Huvenne W; De Neve W
    Radiother Oncol; 2014 Jun; 111(3):388-92. PubMed ID: 24998706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant stereotactic body radiotherapy±cetuximab following salvage surgery in previously irradiated head and neck cancer.
    Vargo JA; Kubicek GJ; Ferris RL; Duvvuri U; Johnson JT; Ohr J; Clump DA; Burton S; Heron DE
    Laryngoscope; 2014 Jul; 124(7):1579-84. PubMed ID: 24123056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aggressive simultaneous radiochemotherapy with cisplatin and paclitaxel in combination with accelerated hyperfractionated radiotherapy in locally advanced head and neck tumors. Results of a phase I-II trial.
    Kuhnt T; Becker A; Pigorsch S; Pelz T; Bloching M; Passmann M; Lotterer E; Hänsgen G; Dunst J
    Strahlenther Onkol; 2003 Oct; 179(10):673-81. PubMed ID: 14566475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Once-daily reirradiation for rectal cancer in patients who have received previous pelvic radiotherapy.
    Ng MK; Leong T; Heriot AG; Ngan SY
    J Med Imaging Radiat Oncol; 2013 Aug; 57(4):512-8. PubMed ID: 23870353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxicity and survival outcomes of hyperfractionated split-course reirradiation and daily concurrent chemotherapy in locoregionally recurrent, previously irradiated head and neck cancers.
    Watkins JM; Shirai KS; Wahlquist AE; Stuart RK; Chaudhary UB; Garrett-Mayer E; Day TA; Gillespie MB; Sharma AK
    Head Neck; 2009 Apr; 31(4):493-502. PubMed ID: 19156831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicity and outcome analysis of patients with recurrent head and neck cancer treated with hyperfractionated split-course reirradiation and concurrent cisplatin and paclitaxel chemotherapy from two prospective phase I and II studies.
    Kramer NM; Horwitz EM; Cheng J; Ridge JA; Feigenberg SJ; Cohen RB; Nicolaou N; Sherman EJ; Babb JS; Damsker JA; Langer CJ
    Head Neck; 2005 May; 27(5):406-14. PubMed ID: 15719391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.